Successfully reported this slideshow.
1<br />National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN)<br />Ohio Valley Node (OVN)<br />Erin L. Wins...
2<br />“BRIDGING THE GAP”<br />The Institute of Medicine (IOM) studied the status of drug dependence treatment <br />Concl...
3<br />Goals of the CTN<br />Test & adapt evidence-based treatment in community settings<br />Deliver research findings in...
4<br />CTN Network Organization<br />1. Center for the Clinical Trials Network<br />Director – Dr. Betty Tai<br />14 Staff...
5<br />Map of the CTN Nodes<br />
6<br />Organization of the CTN Nodes<br />13 CTN Nodes:<br /><ul><li>Applachian Tri-State
Delaware Valley
Florida Node Alliance
Greater New York
Mid-Atlantic
New England Consortium
Ohio Valley
Pacific Northwest
Pacific Region
Southern Consortium
Southwest
Texas
Western States</li></ul>Regional Research & Training Centers or Nodes<br />Clinical Treatment Program<br />
7<br />CTN Nationwide Activities (1999 – 2010)<br />45 trials initiated (24 ancillary studies)<br />28 trials completed<br...
8<br />Status of CTN Trials (1999 – 2010)<br />Development <br />& <br />Review<br />Recruitment <br />& <br />Data Collec...
9<br />CTN Governance Structure<br />CTN<br />Steering Committee<br />Executive Committee<br />Research <br />Development<...
10<br />CTPs Representative’s Role in CTN<br />National Steering Committee<br />Special Interest Groups (SIGs)<br />Minori...
Meet the OVN CTN Team<br />Dr. Gene Somoza, Director                           Dr. Theresa Winhusen, Co-Director<br />11<b...
Upcoming SlideShare
Loading in …5
×

Winstanley_OVN_Overview

393 views

Published on

Slide presentation is an overview of the Ohio Valley Node (OVN) of the NIDA CTN and it was presented at the November 2010 OVN Steering Committee conference call.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Winstanley_OVN_Overview

  1. 1. 1<br />National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN)<br />Ohio Valley Node (OVN)<br />Erin L. Winstanley, Ph.D.<br />OVN Dissemination Director<br />winstanley@carc.uc.edu<br />November 19th, 2010, OVN Steering Committee Meeting<br />
  2. 2. 2<br />“BRIDGING THE GAP”<br />The Institute of Medicine (IOM) studied the status of drug dependence treatment <br />Conclusion: a significant gap between treatment found effective in research and the treatment offered in the community (Bridging the Gap, 1995)<br />
  3. 3. 3<br />Goals of the CTN<br />Test & adapt evidence-based treatment in community settings<br />Deliver research findings into the hands of clinicians and other professionals who can make the best use of them – fast<br />Train staff, expanding the reach of evidence-supported treatments<br />
  4. 4. 4<br />CTN Network Organization<br />1. Center for the Clinical Trials Network<br />Director – Dr. Betty Tai<br />14 Staff members<br />2. Nodes or Regional Research & Training Centers (RTTCs)<br /><ul><li>13 Nodes throughout the United States</li></ul>3. Community Treatment Programs (CTPs) nested within nodes<br />4. Clinical Coordinating Center<br /><ul><li> The EMMES Corporation</li></ul>5. Data and Statistics Center <br />
  5. 5. 5<br />Map of the CTN Nodes<br />
  6. 6. 6<br />Organization of the CTN Nodes<br />13 CTN Nodes:<br /><ul><li>Applachian Tri-State
  7. 7. Delaware Valley
  8. 8. Florida Node Alliance
  9. 9. Greater New York
  10. 10. Mid-Atlantic
  11. 11. New England Consortium
  12. 12. Ohio Valley
  13. 13. Pacific Northwest
  14. 14. Pacific Region
  15. 15. Southern Consortium
  16. 16. Southwest
  17. 17. Texas
  18. 18. Western States</li></ul>Regional Research & Training Centers or Nodes<br />Clinical Treatment Program<br />
  19. 19. 7<br />CTN Nationwide Activities (1999 – 2010)<br />45 trials initiated (24 ancillary studies)<br />28 trials completed<br />More than 11,777 participants enrolled in trials to date<br />188 scientific papers published<br />Data from 23 trials now available on CTN website for public use<br />
  20. 20. 8<br />Status of CTN Trials (1999 – 2010)<br />Development <br />& <br />Review<br />Recruitment <br />& <br />Data Collection<br />Data Analysis<br />&<br />Manuscript Preparation<br />Publication<br />& Dissemination<br />CTN 0001 CTN 0013<br />CTN 0002 CTN 0014<br />CTN 0003 CTN 0015<br />CTN 0004 CTN 0016<br />CTN 0005 CTN 0017<br />CTN 0006 CTN 0018<br />CTN 0007 CTN 0019<br />CTN 0008 CTN 0020<br />CTN 0009 CTN 0021<br />CTN 0010 CTN 0029<br />CTN 0011 CTN 0039<br />CTN 0012 CTN 0040<br />CTN 0030 LT FU<br />CTN 0037<br />CTN 0038<br />CTN 0044<br />CTN 0046<br />CTN 0047<br />CTN 0045<br />CTN 0048<br />CTN 0049<br />CTN 0050<br />CTN 0051<br />CTN 0027<br />CTN 0028<br />CTN 0030 main<br />CTN 0031<br />CTN 0032<br />CTN 0033<br />CTN 0034<br />CTN 0035<br />CTN 0036<br />CTN 0041<br />CTN 0042<br />CTN 0043<br />
  21. 21. 9<br />CTN Governance Structure<br />CTN<br />Steering Committee<br />Executive Committee<br />Research <br />Development<br />Research <br />Utilization<br />Publications<br />Committee<br />
  22. 22. 10<br />CTPs Representative’s Role in CTN<br />National Steering Committee<br />Special Interest Groups (SIGs)<br />Minority, Gender, HIV, Dissemination, Psychology, etc. <br />Concept & Protocol Development <br />Participation in Clinical Trials<br />
  23. 23. Meet the OVN CTN Team<br />Dr. Gene Somoza, Director Dr. Theresa Winhusen, Co-Director<br />11<br />Jennifer Anadio, Protocol Manager<br />Angela Casey-Willingham, Node Coordinator<br />Jim Casey-Willingham, IT Manager<br />Ronald Coleman, Study Staff<br />Emily Dorer, Regulatory Director<br />Matthew Elmore, Business Operations Coordinator<br />Frankie Kropp, Training Director<br /> Teresa Latham, Protocol Manager<br /> Stephanie Lee, Study Staff<br /> Daniel Lewis, Systems Analyst<br /> Sharon Pickrel, Quality Assurance Monitor<br /> Peggy Somoza, Quality Assurance<br /> Jeff Theobold, Study Staff<br /> Dr. Erin Winstanley, Dissemination Director<br />
  24. 24. 12<br />Ohio Valley Node (OVN) CTPs<br /><ul><li>CenterPoint, Inc. (Lincoln, NE)
  25. 25. CenralDuPage Hospital (Winfield, IL)
  26. 26. Centro de Salud Esperanza (Chicago, IL)
  27. 27. City/County Alcohol and Drug Program (Rapid City, SD)
  28. 28. Cumberland Heights (Nashville, TN)
  29. 29. DCCA, Inc. (Lawrence, KS)
  30. 30. East Indiana Treatment Center (Lawrenburg, IN)
  31. 31. Forest Park Family Practice Center (Forest Park, OH)
  32. 32. Gibson Recovery Center, Inc. (Cape Girardeau, MO)
  33. 33. Haymarket Center (Chicago, IL)
  34. 34. Heartview Foundation (Bismarck, ND)
  35. 35. Hegira Programs, Inc. (Westland, MI)
  36. 36. Jackson Recovery Center (Sioux City, IA)
  37. 37. Jefferson Alcohol and Drug Abuse Center (Louisville, KY)
  38. 38. Maryhaven, Inc. (Columbus, OH)
  39. 39. Meridian Behavioral Health, LLC (New Brighton, MN)
  40. 40. Midtown Community Mental Health Center (Indianapolis, IN)
  41. 41. Mount Sinai Hospital Emergency Department (Chicago, IL)
  42. 42. Prestera Center for Mental Health Services, Inc. (Huntington, WV)
  43. 43. Shorehaven Behavioral Health, Inc. (Brown Deer, WI)
  44. 44. The Crossroads Center (Cincinnati, OH)
  45. 45. University of Cincinnati Infectious Disease Center (Cincinnati, OH)
  46. 46. University of Cincinnati Emergency Medicine Department (Cincinnati, OH)</li></ul>15 States<br /> 23 Programs<br />Grant renewed through August 2015<br />
  47. 47. Map of OVN CTPs<br />13<br />
  48. 48. OVN Senior Investigators<br />……expanding the breadth of our expertise<br />R. Anthenelli, MD (Univ. of Cincinnati; Cincinnati VA Hosp.)<br />M. DelBello, MD (Univ. of Cincinnati)<br />P. Horn, PhD (Univ. of Cincinnati)<br />G. Lucas, MD, PhD (Johns Hopkins Univ.)<br />P. Keck, MD (Univ. of Cincinnati; Lindner Center of HOPE)<br />S. Ondersma, PhD (Wayne State Univ.)<br />K. Silverman, PhD (Johns Hopkins Univ.)<br />S. Strakowski, MD (Univ. of Cincinnati)<br />S. Walsh, PhD (Univ. of Kentucky)<br />L. Wulsin, MD (Univ. of Cincinnati)<br />14<br />
  49. 49. Network & Agency Representatives<br />……connecting us with other organizational networks<br />Lonnetta Albright, Great Lakes ATTC<br />Pat Stilen, LCSW; Mid-America ATTC<br />Paula Horvatich, PhD; Mid-Atlantic ATTC<br />Anne Helene Skinstad; Prairielands ATTC<br />Sandy Starr, MSW, LISW; Ohio Single State Agency<br />Carl Leukefeld, DSW; CJ-DATS Network<br />Joel Tsevat, MD; CTSA Consortium<br />Carl Fichtenbaum, MD; ACTG Network<br />15<br />
  50. 50. Participation in 25 trials to date<br />Active trials include: <br /><ul><li>CTN-0047Screening Motivational Assessment and Referral to Treatment in Emergency Departments (SMART-ED)
  51. 51. CTN-0046Smoking Cessation and Stimulant Treatment (C-CAST)
  52. 52. CTN-044-A-2 Acceptability of Web-Delivered, Evidence-based, Psychosocial Intervention among Individuals with Substance Use Disorders who Identify as American Indian/Alaska Native
  53. 53. CTN-0044 Web-Delivered, Evidence-based, Psychosocial Intervention among Individuals with Substance Use Disorders
  54. 54. CTN-0037 Exercise as a Treatment for Substance Use Disorders (STRIDE)</li></ul>16<br />OVN Trial Participation<br />
  55. 55. Dissemination<br />17<br />@NIDANews<br />ATTCs Quarterly E-Publication “The Bridge: Linking Science & Service” <br />http://www.ctndatashare.org/<br />@samsagov<br />http://www.drugabuse.gov/CTN/<br />@NIDABlending<br />@ATTCnetwork<br />
  56. 56. 18<br />NIDA/SAMHSA Blending Products<br />Print Materials: <br />Buprenorphine Treatment for Young Adults<br />The Science of Treatment: Dissemination of Research-Based Drug Addiction Treatment Findings<br />Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency<br />Short Term Opioid Withdrawal using Buprenorphine<br />Treatment Planning MATRS – Utilizing the Addiction Severity Index (ASI) to Make Required Data Collection Useful<br />Videos: <br />Buprenorphine Treatment: A Training for Multidisciplinary Addiction Professionals<br />Promoting Awareness of Motivational Incentives (PAMI)<br />
  57. 57. CTN Dissemination Library<br />19<br />
  58. 58. CTN’s 10th Anniversary<br />A special supplemental issues of the Journal of Substance Abuse Treatment (JSAT)<br />"A Decade of Research by the National Drug Abuse Treatment Clinical Trials Network” <br />June 2010<br />E-mail for free copy of articles<br />info@ctndisseminationlibrary.org<br />20<br />
  59. 59. OVN Dissemination<br />47 Journal articles<br />27 Presentations<br />30 Posters<br />14 Brochures<br />21<br />………social media as a dissemination tool<br /><ul><li>Facebook “Ohio Valley Node of the NIDA CTN”
  60. 60. 18 Likes
  61. 61. Twitter “AODtxWorks”
  62. 62. 37 Tweets, Following 46, Follwers 14
  63. 63. Tweetdeck
  64. 64. Cross-post to Twitter, Facebook, & LinkedIn</li></li></ul><li>What are we Tweeting?<br />NextGen Ambulatory EHR 5.6 - first EHR with behavioral <br /> health certification http://bit.ly/b8bHCw<br />FDA approves Vivitrol (long acting naltrexone) for opiate dependence http://fb.me/LRIr8zEq<br />Congratulations Dr. Winhusen on receiving the Besteman Award for your extraordinary contributions to the NIDA CTN!<br />Study by Nutt & colleagues (Lancet, 2010) found the most harmful drugs are: 1) alcohol, 2) heroin, and 3) crack cocaine http://n.pr/aWho5w<br />AAFP Resources Guide Members in Coding, Getting Paid for Tobacco Cessation Counseling http://fb.me/D63sSVCL<br />Dr. Greg Brigham presented the results of his pilot study on long-term care for chronic substance dependence at... http://fb.me/Gq34ZBGC<br />Financial incentives are being used to encourage healthy behaviors such as weight loss & reduce rates of smoking,... http://fb.me/JB3btuhL<br />22<br />
  65. 65. Thank You!<br />23<br />

×